{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:09:51Z","timestamp":1780708191041,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T00:00:00Z","timestamp":1640563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004242","name":"Princess Nourah bint Abdulrahman University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jsps.2021.12.006","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T17:02:23Z","timestamp":1641315743000},"page":"205-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Patterns of antiseizure medication prescription in pregnancy and maternal complications in women with epilepsy: A retrospective study in Saudi Arabia"],"prefix":"10.1007","volume":"30","author":[{"given":"Bshra A.","family":"Alsfouk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal Rashed","family":"Almarzouqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"Alageel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha A.","family":"Alsfouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz","family":"Alsemari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2021.12.006_b0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/seiz.1998.0239","article-title":"Outcome of pregnancies in epileptic women: a study in Saudi Arabia","volume":"8","author":"Albunyan","year":"1999","journal-title":"Seizure"},{"issue":"9","key":"10.1016\/j.jsps.2021.12.006_b0010","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jsps.2021.08.002","article-title":"Antiseizure medications use during pregnancy and congenital malformations: a retrospective study in Saudi Arabia","volume":"29","author":"Alsfouk","year":"2021","journal-title":"Saudi Pharm. J."},{"issue":"1","key":"10.1016\/j.jsps.2021.12.006_b0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.17712\/nsj.2020.1.20190077","article-title":"Prevalence of epilepsy in Saudi pregnant women and possible effects of anti-epileptic drugs on pregnancy outcomes","volume":"25","author":"AlSheikh","year":"2020","journal-title":"Neurosciences (Riyadh)"},{"key":"10.1016\/j.jsps.2021.12.006_b0020","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","volume":"122","author":"American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","year":"2013","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.jsps.2021.12.006_b0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40264-013-0052-8","article-title":"Effects of Maternal Epilepsy and Antiepileptic Drug Use during Pregnancy on Perinatal Health in Offspring: Nationwide, Retrospective Cohort Study in Finland","volume":"36","author":"Artama","year":"2013","journal-title":"Drug Saf."},{"issue":"9","key":"10.1016\/j.jsps.2021.12.006_b0030","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/epi.12302","article-title":"Seizure control and treatment changes in pregnancy: Observations from the EURAP epilepsy pregnancy registry","volume":"54","author":"Battino","year":"2013","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.jsps.2021.12.006_b0035","doi-asserted-by":"crossref","first-page":"e034829","DOI":"10.1136\/bmjopen-2019-034829","article-title":"Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy: a French nationwide population-based cohort study","volume":"10","author":"Bloti\u00e8re","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jsps.2021.12.006_b0040","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/ppe.12004","article-title":"Trends in the use of antiepileptic drugs among pregnant women in the US, 2001\u20132007: a medication exposure in pregnancy risk evaluation program study","volume":"26","author":"Bobo","year":"2012","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"10.1016\/j.jsps.2021.12.006_b0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.seizure.2015.02.018","article-title":"Obstetrical complications in women with epilepsy","volume":"28","author":"Borthen","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.jsps.2021.12.006_b0050","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/j.1471-0528.2010.02694.x","article-title":"Delivery outcome of women with epilepsy:a population-based cohort study","volume":"117","author":"Borthen","year":"2010","journal-title":"BJOG"},{"issue":"8","key":"10.1016\/j.jsps.2021.12.006_b0055","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1471-0528.2011.03004.x","article-title":"Obstetric outcome in women with epilepsy: a hospital-based, retrospective study","volume":"118","author":"Borthen","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.jsps.2021.12.006_b0060","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/j.1471-0528.2009.02354.x","article-title":"Complications during pregnancy in women with epilepsy: population-based cohort study","volume":"116","author":"Borthen","year":"2009","journal-title":"BJOG"},{"issue":"6","key":"10.1016\/j.jsps.2021.12.006_b0065","article-title":"Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child","volume":"2020","author":"Bromley","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"18","key":"10.1016\/j.jsps.2021.12.006_b0070","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1212\/WNL.0000000000003157","article-title":"Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate","volume":"87","author":"Bromley","year":"2016","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jsps.2021.12.006_b0075","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/jnnp-2013-306318","article-title":"Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers","volume":"85","author":"Campbell","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jsps.2021.12.006_b0080","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneurol.2009.142","article-title":"Affect of Seizures During Gestation on Pregnancy Outcomes in Women With Epilepsy","volume":"66","author":"Chen","year":"2009","journal-title":"Arch. Neurol."},{"issue":"16","key":"10.1016\/j.jsps.2021.12.006_b0085","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.jsps.2021.12.006_b0090","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/pds.5035","article-title":"Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006\u20132016: A study in the five Nordic countries, United States, and Australia","volume":"29","author":"Cohen","year":"2020","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"2","key":"10.1016\/j.jsps.2021.12.006_b0095","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yebeh.2013.08.001","article-title":"Fetal antiepileptic drug exposure: Adaptive and emotional\/behavioral functioning at age 6years","volume":"29","author":"Cohen","year":"2013","journal-title":"Epilepsy Behav."},{"issue":"4","key":"10.1016\/j.jsps.2021.12.006_b0100","doi-asserted-by":"crossref","first-page":"e020998","DOI":"10.1136\/bmjopen-2017-020998","article-title":"Hypertensive pregnancy complications in women with epilepsy and antiepileptic drugs: a population-based cohort study of first pregnancies in Norway","volume":"8","author":"Danielsson","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jsps.2021.12.006_b0105","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/epi.13671","article-title":"Instruction manual for the ILAE 2017 operational classification of seizure types","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"issue":"21","key":"10.1016\/j.jsps.2021.12.006_b0110","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hernandez-Diaz","year":"2012","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.jsps.2021.12.006_b0115","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/pds.4897","article-title":"Prescription of antiepileptic medicines including valproate in pregnant women: A study in three European countries","volume":"28","author":"Hurault\u2010Delarue","year":"2019","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"3","key":"10.1016\/j.jsps.2021.12.006_b0120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.yebeh.2007.08.012","article-title":"Obstetric risks for women with epilepsy during pregnancy","volume":"11","author":"Kaplan","year":"2007","journal-title":"Epilepsy Behav."},{"issue":"1","key":"10.1016\/j.jsps.2021.12.006_b0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/14767050500434096","article-title":"Pregnancy and perinatal outcome in epileptic women: A population-based study","volume":"19","author":"Katz","year":"2006","journal-title":"J. Matern. Fetal Med."},{"issue":"11","key":"10.1016\/j.jsps.2021.12.006_b0130","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/epi.12758","article-title":"Birth outcomes after prenatal exposure to antiepileptic drugs\u2014A population-based study","volume":"55","author":"Kilic","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.jsps.2021.12.006_b0135","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.seizure.2019.05.009","article-title":"Outcomes of pregnant women with refractory epilepsy","volume":"69","author":"Kusznir Vitturi","year":"2019","journal-title":"Seizure"},{"issue":"10","key":"10.1016\/j.jsps.2021.12.006_b0140","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1007\/s00415-009-5222-3","article-title":"No increase in adverse pregnancy outcomes for women receiving antiepileptic drugs","volume":"256","author":"Lin","year":"2009","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jsps.2021.12.006_b0145","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/WNL.0b013e31827f0874","article-title":"Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers","volume":"80","author":"Mawhinney","year":"2013","journal-title":"Neurology"},{"issue":"16","key":"10.1016\/j.jsps.2021.12.006_b0150","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jsps.2021.12.006_b0155","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jsps.2021.12.006_b0160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yebeh.2018.04.009","article-title":"Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy","volume":"84","author":"Meador","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jsps.2021.12.006_b0165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.jsps.2021.12.006_b0170","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jamaneurol.2017.1310","article-title":"Association Between Pregnancy and Perinatal Outcomes Among Women With Epilepsy","volume":"74","author":"Razaz","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jsps.2021.12.006_b0175","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.jsps.2021.12.006_b0180","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1212\/WNL.0b013e3182088297","article-title":"Child development following in utero exposure: levetiracetam vs sodium valproate","volume":"76","author":"Shallcross","year":"2011","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.jsps.2021.12.006_b0185","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/j.1528-1167.2009.02093.x","article-title":"Utilization of antiepileptic drugs during pregnancy: Comparative patterns in 38 countries based on data from the EURAP registry","volume":"50","author":"The EURAP Study Group","year":"2009","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.jsps.2021.12.006_b0190","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/epi.13632","article-title":"Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India","volume":"58","author":"Thomas","year":"2017","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.jsps.2021.12.006_b0195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.seizure.2008.08.010","article-title":"Maternal and obstetric outcome of women with epilepsy","volume":"18","author":"Thomas","year":"2009","journal-title":"Seizure"},{"key":"10.1016\/j.jsps.2021.12.006_b0200","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","article-title":"Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry","volume":"17","author":"Tomson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jsps.2021.12.006_b0205","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1684\/epd.2019.1105","article-title":"Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy","volume":"21","author":"Tomson","year":"2019","journal-title":"Epileptic Disord."},{"issue":"7","key":"10.1016\/j.jsps.2021.12.006_b0210","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/epi.13021","article-title":"Valproate in the treatment of epilepsy in girls and women of childbearing potential","volume":"56","author":"Tomson","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.jsps.2021.12.006_b0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0404.2009.01260.x","article-title":"Changing patterns of antiepileptic drug use in pregnant Australian women","volume":"121","author":"Vajda","year":"2010","journal-title":"Acta Neurol. Scand."},{"issue":"9","key":"10.1016\/j.jsps.2021.12.006_b0220","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1111\/j.1528-1167.2009.02147.x","article-title":"Pregnancy, delivery, and outcome for the child in maternal epilepsy","volume":"50","author":"Veiby","year":"2009","journal-title":"Epilepsia"},{"issue":"10006","key":"10.1016\/j.jsps.2021.12.006_b0225","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(15)00045-8","article-title":"Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis","volume":"386","author":"Viale","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jsps.2021.12.006_b0230","first-page":"Cd010224","article-title":"Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child","volume":"11","author":"Weston","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"12","key":"10.1016\/j.jsps.2021.12.006_b0235","doi-asserted-by":"crossref","first-page":"e0189497","DOI":"10.1371\/journal.pone.0189497","article-title":"Antiepileptic drug use among women from the Taiwanese Registry of Epilepsy and Pregnancy: Obstetric complications and fetal malformation outcomes","volume":"12","author":"Yeh","year":"2017","journal-title":"PLoS ONE"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016421002553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016421002553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:27:39Z","timestamp":1736184459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016421002553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1319016421002553"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2021.12.006","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of antiseizure medication prescription in pregnancy and maternal complications in women with epilepsy: A retrospective study in Saudi Arabia","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2021.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}